Medical Countermeasures Coalition (MC2)
Advancing Public Health Security Through Sound Policy and Partnerships
The Medical Countermeasures Coalition (MC2) is committed to fostering innovation and collaboration. The coalition is made of non-profits, universities, and leading medical manufacturers working together to protect medical supply chains and protect against public health threats.
About Medical Countermeasures Coalition
Medical countermeasures (MCMs) are essential for addressing public health emergencies. Pandemics, bioterrorism, and natural disasters all require swift and effective responses. MCMs include vaccines, antiviral drugs, and diagnostic tools.
To ensure these solutions are accessible, MC2 focuses on key areas:
- Policy Innovation: We develop and champion policies to support technological innovation, advanced manufacturing, and resilient supply chain.
- Public-Private Partnerships: Our experts have served as leaders in both the public and private sector and convene key actors from industry, academia, and government.
- Global Preparedness: Biothreats can emerge anywhere. We work to build a resilient supply chain and stockpile to protect against public health threat
Our Members
MC2 comprises organizations dedicated to building an effective medical countermeasure enterprise, fostering innovation, and enhancing public health preparedness.
Our Members
MC2 comprises organizations dedicated to building an effective medical countermeasure enterprise, fostering innovation, and enhancing public health preparedness.
Our Mission: Advancing Public Health and Security
The mission of the Medical Countermeasures Coalition (MC2) is to convene leaders from academia, industry, and philanthropy across the medical countermeasure coalition. We organize and represent key actors to educate policymakers and the public about how to support technological innovation, supply chain resilience, strategic stockpiles, and domestic manufacturing.
Driving Sound Policy and Public-Private Partnerships
MC2 enhances national public health security and emergency preparedness. Therefore, we:
- Support Domestic Manufacturing: Because reliable supply chains are critical, we promote local production as emphasized by Biomedical Advanced Research and Development Authority (BARDA).
- Facilitate Medical Innovation: We encourage the development of vaccines, drugs, and therapies.
- Strengthen Partnerships: We collaborate across sectors to build a resilient medical countermeasure infrastructure.
